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Optogenetics enables manipulation of biological processes with light at high spatio-temporal
resolution to control the behavior of cells, networks, or even whole animals. In contrast to the
performance of excitatory rhodopsins, the effectiveness of inhibitory optogenetic tools is still
insufficient. Here we report a two-component optical silencer system comprising photo-
activated adenylyl cyclases (PACs) and the small cyclic nucleotide-gated potassium channel
SthK. Activation of this ‘PAC-K’ silencer by brief pulses of low-intensity blue light causes
robust and reversible silencing of cardiomyocyte excitation and neuronal firing. In vivo
expression of PAC-K in mouse and zebrafish neurons is well tolerated, where blue light
inhibits neuronal activity and blocks motor responses. In combination with red-light absorb-
ing channelrhodopsins, the distinct action spectra of PACs allow independent bimodal control
of neuronal activity. PAC-K represents a reliable optogenetic silencer with intrinsic amplifi-
cation for sustained potassium-mediated hyperpolarization, conferring high operational light
sensitivity to the cells of interest.
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Reversible light-based silencing is a key requirement forinvestigations into the role of genetically defined cellpopulations, for example to explore effects of individual
neurons in controlling network activity and behavior1, or to
investigate the effects of local conduction block zones in the
heart2. Current optogenetic inhibitors comprise inward-directed
chloride pumps, outward-directed proton or sodium pumps, or
chloride-conducting channelrhodopsins3–9. Their application,
however, can suffer from paradoxical effects due to unintended
changes in ion distributions10–13, and most of them require high
expression levels and persistent high-intensity illumination for
efficient inhibition of cell activity. The generation of a light-
activated potassium (K+) channel has the potential to overcome
many of these limitations, primarily because K+ conductances
underlie the resting state of excitable cells, so their activation can
generate strong inhibition without major changes in transmem-
brane ion gradients. However, efforts to generate a widely usable
light-gated K+ conductance have not been successful so far.
Available synthetic light-gated K+ channels suffer from poor
expression in mammalian cells14, the requirement for additional
cofactors15–17, irreversibility of activation18, or the large size of
the encoding genes19, all of which have hampered their wide-
spread application.
In order to establish a light-controlled K+-based hyperpolar-
ization tool, we conceived an optogenetic system consisting of a
cyclic nucleotide-gated (CNG) K+ channel and a photo-activated
nucleotidyl cyclase (PAC). This concept requires a cyclic
nucleotide-gated channel with high preference for K+ over Na+
and H+ that shows high functional expression levels in mamma-
lian cells. Classic mammalian CNG channels or hyperpolarization-
activated and cyclic nucleotide-gated (HCN) channels do not show
a high K+ selectivity over Na+ and H+20,21. A cGMP-gated K+
channel was found in Arbacia punctulata sperm22, but this channel
bears a pseudotetrameric architecture and is therefore too large for
applications relying on viral gene transfer. For the prokaryotic K+
channels MLoK1 from Mesorhizobium loti23 or MmaK from
Magnetospirillum magnetotacticum24 evidence for functional
expression in mammalian cells is lacking25. In contrast, the small
cAMP-gated K+ channel SthK from Spirochaeta thermophila is
well expressed in mammalian cells, and it carries an exceptionally
large single channel current ensuring robust repolarization or
hyperpolarization26–28, rendering it the most promising candidate
for a silencer system.
PACs are blue-light-activated cyclases consisting of a blue light
receptor using flavin (BLUF) domain coupled via a linker to the
cyclase domain. They were identified in various species, providing
a range of light sensitivities and enzyme kinetics29. The first-
discovered PACα and PACβ from Euglenoid algae30 are large
proteins of 105 and 90 kDa, respectively, and only poorly soluble.
In contrast, the small bPAC (33 kDa) of the soil bacterium Beg-
giatoa and similar small PACs from other species can be well
expressed in a variety of host cells29,31–33.
We characterized various combinations of the SthK channel
with small PACs in cell lines to obtain robust light-activated K+
currents. Among these, the combinations of bPAC or TpPAC
with SthK showed most promising results, and were further
validated for general applicability in excitable cells, including
cardiomyocytes and different types of neurons. The ‘PAC-K’
silencer efficiently suppresses action potential (AP) generation
and contraction in cardiomyocytes, and neuronal firing both
in vitro and in vivo. We found that the combination of bPAC and
SthK yields a highly light sensitive K+-based hyperpolarizer that
requires minimal illumination for long lasting, fully reversible
hyperpolarization, thereby providing an exceptionally efficient
optogenetic silencer. Importantly, the K+ currents induced by
PAC-K activation mimic nature’s own repolarization mechanism
for resting cell polarization, which is energetically favorable and
not associated with major alterations in other ion concentration
gradients.
Results
Engineering of PAC-K. We tested two single-vector coexpression
strategies for PACs and SthK (Fig. 1a): either with the PAC
separated from the channel by a self-cleaving 2A peptide at the
SthK C-terminus (split-PAC-K), or with the PAC N-terminally
fused to SthK (fused-PAC-K). The design of the split system
aimed to exclude any impairment of SthK function by the
attachment of the PAC, while the fused system should achieve
very short cAMP diffusion distances between enzyme and
channel. In ND7/23 cells expressing split-bPAC-K with bPAC
from Beggiatoa31, a 10-ms light pulse evoked intensity-dependent
outward currents that lasted for several seconds (Fig. 1b, c;
Supplementary Fig. 1a). At 50% light saturation (EC50: 0.86 mW
mm−2), currents reached a maximum within ∼12 s (Supple-
mentary Fig. 1a), and decayed exponentially with τoff= 33 ± 17 s
(median ± standard deviation). To achieve faster off-kinetics we
tested less active PACs from Naegleria gruberi (NgPAC1)34,
Turneriella parva (TpPAC)35, Oscillatoria acuminate (OaPAC)36,
and Ilumatobacter coccineus (IcPAC) (Fig. 1b, c). Among these,
TpPAC displayed four times faster off-kinetics and a 10 times
reduced light sensitivity (Fig. 1c, e). Comparison of various split-
PAC-K versions with the widely used light-driven H+ pump
Arch33,4 showed that only split-bPAC-K provided a higher
effective light sensitivity at EC50 than Arch3, whereas other PAC-
expressing cells were less sensitive (Supplementary Fig. 1b). We
surmise that this result might be due to a maximal activation of
SthK at light intensities not saturating bPAC, because photon
capture of flavins is lower compared to retinal, due to a smaller
extinction coefficient37. However, all split-PAC-K versions
transported considerably more charges per absorbed photon than
Arch3 (up to a factor of 3 × 104) due to the long-lasting activation
of currents (Fig. 1c; Supplementary Fig. 1b). We simultaneously
monitored the photoactivated K+ current and intracellular cAMP
levels using a red fluorescent cAMP reporter38 (Fig. 1d). Current
activation slightly trailed the cAMP increase (τcurrent/τcAMP=
1.52 ± 1.26, n= 20 from seven cells) while current deactivation
preceded the decline in cAMP (τcurrent/τcAMP= 0.33 ± 0.22, n= 9
from three cells). Comparing the fused-PAC-K and split-PAC-K
strategies for both bPAC and TpPAC revealed similar
cellular light sensitivities and current kinetics for both PAC-K
systems, with smaller photocurrents for fused-bPAC-K
(Fig. 1e–h), and poor photocurrents and onset kinetics
for fused-TpPAC-K compared to split-TpPAC-K (Fig. 1f, g).
We also assessed SthK activation by the bPAC-S27A variant
with 15-nm red-shifted absorbance and further reduced dark
activity39, but found no difference compared to activation
by bPAC (Supplementary Fig. 1d–g). In summary, both fused-
PAC-K and split-PAC-K systems were identified as promising
silencing tools.
Split-bPAC-K silences cardiomyocyte activity. To test the
bPAC-K system in excitable cells, we first transduced rabbit
primary ventricular cardiomyocytes with adenovirus for fused-
bPAC-K or split-bPAC-K. While the fusion construct failed to
elicit any light-induced response, split-bPAC-K-expressing myo-
cytes (Fig. 2a) showed robust outward currents following short
blue light exposure (10 ms, 460 nm). Amplitude and duration of
currents were graded with light intensity (Fig. 2b–d). Single light
pulses suppressed electrically evoked APs for extended time
periods (283 ± 43 s at 4 mWmm−2, Fig. 2e), with the duration of
the AP-free interval scaling linearly with the K+ current duration
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(Fig. 2f). AP duration at 90% repolarization (APD90) recovered to
baseline values within 10 s after reoccurrence of excitability, and
importantly, was not different from APD90 measured in non-
transduced control cells (Fig. 2g). Light-activation of split-bPAC-
K also effectively silenced cardiomyocyte contractions (Fig. 2h). A
complex illumination protocol (Fig. 2i) revealed a direct depen-
dence of the contraction-free interval on light-pulse duration
(Fig. 2j), and highly reproducible contraction-free intervals that
are independent of previous inhibitory events (Fig. 2k).
PAC-K characterization in neurons. Next we assessed the
expression of both PAC-K variants in cultured hippocampal
neurons. The small size of the PAC-K-encoding DNA sequences
allowed gene delivery by a single adeno-associated virus (AAV).
Expression of either fused-bPAC-K or split-bPAC-K did not
affect intrinsic electrophysiological membrane properties (Sup-
plementary Table 1). In cells expressing split-bPAC-K, 100 ms
pulses of 385 or 470 nm light with >1 mWmm−2 shifted the
minimal current necessary to evoke an AP (rheobase) by more
than 600 pA and suppressed spiking by hyperpolarization for up
to 1 min (Fig. 3a–c). SthK-mediated changes in membrane vol-
tage were in accordance with the reversal potential of K+
(Fig. 3d). The underlying outward currents depended on the
intensity of the applied light pulse (Supplementary Fig. 2a–e),
with peak amplitudes of 861 ± 119 pA and maximum duration of
81 ± 9 s. Importantly, split-bPAC-K functioned as an integrator of
the activation light. When increasing the light pulse duration
from 100ms to several seconds, we were able to elicit sustained
hyperpolarizing currents with light intensities as low as 0.4 or
0.04 mWmm−2 (Fig. 3e). Increasing the ambient temperature
from 20 to 35 °C shortened the current rise-time and duration,
but did not change the amplitude (Fig. 3f). The hyperpolarization
was specifically mediated by activation of the SthK channel, as
blue light-exposure of cells expressing only bPAC caused small,
depolarizing currents of −36.1 ± 7.4 pA (Supplementary Fig. 2f,
g). Split-TpPAC-K also elicited hyperpolarizing currents in neu-
rons, but required 10× higher light intensities for efficient acti-
vation compared to split-bPAC-K (Supplementary Fig. 3a). Split-
TpPAC-K-mediated currents were four times faster compared to
split-bPAC-K, but showed a more pronounced run-down during
repetitive activation (Supplementary Fig. 3b–e).
Since bPAC is specifically activated at wavelengths <500 nm
(Supplementary Fig. 1g), we tested whether one can optically
elicit independent excitation and inhibition in cultured neurons
coexpressing split-bPAC-K and the red-shifted channelrhodopsin
bReaChES40. In whole-cell current-clamp mode we repetitively
triggered APs by bReaChES activation with 550 nm light pulses.
Single 100 ms pulses of 385 or 470 nm light abolished bReaChES-
driven spiking in an intensity-dependent manner (Fig. 4a–c).
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Fig. 1 Optogenetic activation of SthK channels by various PACs in cell lines. a Illustration of the split-PAC-K and fused-PAC-K construct design for SthK co-
expression with PACs. b Photocurrents elicited by different split-PAC-K variants after 10 ms exposure to a 470 nm light pulse. Scale bars: 10 s, 0.5 nA. c
Normalized integrals of photocurrents as a function of the intensity of a 10 ms light pulse. Arrows denote the EC50 for current activation by light (n= 3
cells, two cultures). d Combined whole-cell patch-clamp (black) and optical recording (gray) of a HEK 293 cell expressing fused-bPAC-K and a fluorescent
cAMP sensor. bPAC was excited with two 1 ms light flashes (470 nm). The dotted line indicates the zero current level. Scale bars: 20 s, 20 pA (upper
trace); 20 s, 2000 aU (lower trace). e Comparison of photocurrent amplitudes generated by bPAC or TpPAC and SthK as split or fused constructs. f
Current density comparison at saturating photon exposures (**p < 0.01; ***p= 0.0001, Wilcoxon rank sum test). g, h Latency and photocurrent rise upon
excitation with blue light at different photon densities. In e–h, bPAC and TpPAC were activated for 10 and 100ms, respectively (split-bPAC-K: n= 9, four
cultures; fused-bPAC-K and split-TpPAC-K: n= 10, three cultures; fused-TpPAC-K: n= 8, five cultures). Error bars in all graphs represent SD
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Importantly, split-bPAC-K was completely insensitive to the
green light used for bReaChES activation. In contrast, blue light-
triggered spiking via bReaChES activation, an effect that could be
minimized by using UV light at low intensity for bPAC activation
(Fig. 4d, e). In less invasive cell-attached recordings we further
used independent optical excitation and inhibition by bReaChES
and split-bPAC-K to demonstrate that endogenous ATP levels are
sufficient for repetitive and stable silencing of bReaChES-driven
AP firing (Supplementary Fig. 4).
To test neuronal silencing in a more complex environment, we
injected AAVs encoding either split-bPAC-K (Fig. 5a–f) or fused-
bPAC-K (Fig. 5g, h) into the hippocampus of wild type mice, or a
Cre-dependent version of split-bPAC-K into the hippocampus of
parvalbumin-Cre transgenic mice (Fig. 5a, c). Whole-cell
recordings from both pyramidal and parvalbumin-positive
interneurons in cornu ammonis area 1 (CA1) of acute
hippocampal slices demonstrated that blue light triggers pro-
longed hyperpolarizing photocurrents (Fig. 5b, d). Hyperpolar-
ization was accompanied by a strong reduction in the input
resistance, demonstrating that opening of SthK channels creates a
shunting inhibition that will further reduce the excitatory drive
(Fig. 5b, d). The photoactivated SthK current efficiently
suppressed ramp-induced neuronal firing in all neuron types
tested (Fig. 5e, Supplementary Fig. 5). Of note, repetitive split-
bPAC-K activation by 5 ms light pulses every 20 s persistently
silenced AP firing for minutes (Fig. 5f).
Two-photon excitation laser-scanning microscopy in combina-
tion with fluorescent indicators allows high-resolution fluores-
cence imaging in intact tissues, and single-cell manipulation when
applied for the activation of optogenetic actuators. It has therefore
become a routine method for the interrogation of single-cell
behavior in situ. In accordance with reported two-photon
excitation cross sections of flavoproteins41, we assessed whether
we could activate fused-bPAC-K at 930 nm in individual CA1
pyramidal neurons in acute hippocampal slices. Neuronal firing
was efficiently suppressed by a 50 ms-long two-photon scan on
the somata of individual neurons (Fig. 5g, h).
In vivo silencing of neuronal activity by bPAC-K. Finally, we
assessed the efficacy of the bPAC-K silencer system in vivo.
Silicon probe recordings in anesthetized mice expressing split-
bPAC-K in principal cells revealed reliable inhibition of CA1 unit
activity by a single light flash (Fig. 6a–d). We also recorded
neuronal activity by two-photon in vivo imaging via the
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Fig. 2 Split-bPAC-K efficiently silences primary ventricular cardiomyocytes. a Fluorescence of split-bPAC-K-mCherry expressed in cultured ventricular
cardiomyocytes from rabbit. Scale bar: 20 µm. b, c Photocurrents and quantification of current amplitudes in isolated cardiomyocytes following blue light
stimulation at different light intensities (n= 16 cells, seven cultures). Scale bars: 30 s, 100 pA. d Quantification of split-bPAC-K-mediated photocurrent
duration (time from current onset to 50% current decline after maximum) at different intensities (n > 11 cells, 3–10 cultures). e Inhibition of electrically
evoked APs (10 ms current ramp) by blue light pulse. Insets display response to electrical stimulation at three indicated time points. Scale bars: 30 s, 20
mV (overview trace); 100ms, 20mV (insets). f Duration of AP-free interval after split-bPAC-K activation by 10 ms light pulse as a function of
corresponding photocurrent duration (460 nm, 4 mWmm−2) (n= 9, six cultures). g Quantification of AP duration (APD90) of wildtype (wt) and PAC-K
expressing cardiomyocytes before and after light application (n= 9–10, four cultures). APD90 before light (time point 1 in d) is not significantly different
from APD90 after inhibition (time point 3 in d) (p= 0.3, paired two-tailed t-test) and APD90 of untransduced control cells (p= 0.9, unpaired two-tailed t-
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genetically encoded Ca2+ indicator GCaMP6s42 (Fig. 6e–h).
GCaMP6s was excited at 1000 nm to avoid co-activation of
bPAC41. Baseline activity of hippocampal neurons in mice
expressing both fused-bPAC-K and GCaMP6s was not different
compared to neurons lacking the actuator (0.92 ± 0.05 vs. 1.06 ±
0.1 Hz), highlighting the absence of any identifiable dark activity.
Wide-field illumination (488 nm) robustly and selectively reduced
Ca2+ transients in fused-bPAC-K-expressing neurons (Fig. 6f–h).
In order to assess whether the PAC-K silencer is able to
alter behavior in a well-characterized model animal, we
targeted bPAC-K to zebrafish motor neurons using the
UAS/Gal4 system (Fig. 7a–c), and studied spontaneously
occurring muscle contractions (coils) of the embryos as a
simple form of motor behavior. Under control conditions,
embryos displayed coiling behavior at a frequency of 3–4 coils
per 5 s. Blue light (6 µWmm−2, 1 s) abolished coiling within 5 s
after light on. About 20 s after light off, embryos started to move
again and displayed transiently increased coiling behavior
(ca. six coils per 5 s), compatible with a rebound from the
inhibition state (Fig. 7d, g). Illuminating with further reduced
intensity (2 µWmm−2) for 15 s instead of 1 s did not sig-
nificantly alter the effectiveness of inhibition (n= 28; p > 0.05;
Fig. 7e, h). Non-expressing control fish showed a slight
reduction of coiling activity after blue light application, which
can be explained by photoinhibition of embryonic motor
responses through endogenous, non-visual rhodopsins43.
Consistently, both non-expressing and transgenic fish showed a
similar response to a 625 nm light pulse (Fig. 7f, i). Taken
together, bPAC-mediated activation of SthK mediates robust
silencing of neurons in the vertebrate central nervous system.
Discussion
Considerable efforts have been dedicated to developing tools for
optogenetic inhibition of excitable cells44. Such tools are critical
for understanding the roles of a particular cell type in the com-
plex functional architecture of excitable tissues, such as the heart
and the brain. For their effective use, optogenetic inhibitors must
be (i) reliably targetable to the cells of interest, (ii) allow efficient
and reversible inhibition of AP firing, ideally for variable dura-
tions, and (iii) have no dark activity or paradoxical effects on ion
concentrations that may affect relevant cell and organ functions.
The currently available inhibitory tools do not satisfy all of these
conditions, in particular given that many experimental designs
require prolonged inhibition. Different variants of chloride or
proton pumps have been generated, with the general caveat that
their prolonged activation may change intracellular ion con-
centrations, a phenomenon observed both for the proton pump
Arch312 and the chloride pump eNpHR3.010. This can lead to
paradoxical effects, for instance through changes in the GABA
reversal potential11. For both types of pumps, rebound depolar-
izations after termination of light exposition have been descri-
bed12. Chloride-conducting channelrhodopsins (iChloc, iC++,
and ACRs) have the advantage that, in contrast to ion pumps,
they can produce inhibition by clamping the membrane potential
to the chloride reversal potential7–9. However, activation of
chloride channels suffers not only from the fact that prolonged
chloride fluxes alter intracellular Cl− concentrations, but also
from the observation that they can trigger depolarizing cation
fluxes via voltage-dependent channels in neurons or neuronal
compartments with a high intracellular Cl− concentration, based
on depolarizing Cl− efflux upon light exposure12,44,45. Also the
inhibition of myocardial excitability in this setting46 is based on
depolarization of cells above the excitation threshold, which is
undesirable for rhythm management as it may lead to a poten-
tially arrhythmogenic gain in cellular Ca2+ uptake.
Optogenetic activation of K+ conductances can potentially
overcome these limitations, which has spurred the development
of several light-gated K+ channel systems15–19. The most pro-
mising published example is the engineered blue-light-induced
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current recorded at near-physiological temperature (35 °C) or at room temperature (20 °C) from the same cell. The sequence of recordings at high and
low temperatures was randomized between cells, and parameters were normalized to room-temperature conditions for each neuron (n= 6, three
cultures). One sample t-test: **p < 0.01; ***p < 0.001, ns: not significant. Scale bars in e and f: 5 s, 100 pA. Error bars in all graphs represent SEM
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K+ channel (BLINK1) consisting of a small viral K+ channel
connected to a LOV-Jα photoreceptor module14. BLINK1 is not,
however, robustly expressed in mammalian cells. In contrast, we
demonstrate here that the SthK channel is well expressed in
different cell types, and that the PAC-K constructs allow highly
efficient hyperpolarization via a light-gated K+ conductance in
cell lines, cardiomyocytes, and neurons. Whereas ion pumps such
as halorhodopsin or archaeorhodopsin require continued photon
flux due to the 1:1 photon:ion coupling, PAC-K-mediated
hyperpolarization can be maintained by repetitive brief light
exposure at low frequencies, or continuous illumination at very
low intensities. This allows cell re-polarization or hyperpolariza-
tion over prolonged periods with a minimal photon budget,
avoiding tissue warming and altered blood flow47–50. One should
note though that illumination intensity determines the current
kinetics (Fig. 1, Supplementary Figs. 1 and 2), with higher
intensity providing faster onset, but also longer duration of the
hyperpolarization. Our tool is applicable on time scales from 100
ms up to minutes. However, the tool does not enable fast
manipulations in the millisecond range that might be required for
rapid closed-loop optogenetic control of network activities at >10
Hz. Shorter effect durations can be achieved by using TpPAC
instead of bPAC (Supplementary Fig. 3), but with similar onset
kinetics at saturating light intensities (Fig. 1g). An additional
advantage is the efficient activation of the PAC-K system by two-
photon illumination. Since activation requires only milliseconds
of illumination to trigger K+ currents that last for seconds, PAC-
K allows silencing of defined sets of individual neurons by
sequential optical targeting. The PAC-K construct further pro-
vides the opportunity to combine optically controlled inhibition
with excitation using red-shifted excitatory opsins, such as
C1V151, Chrimson52, ReaChR53, or variants of these. Dual-color
optogenetic excitation/inhibition experiments so far suffered from
spectral overlap of the rhodopsin-based actuators, and required
calibration of the light intensities for optimal bidirectional control
of membrane voltage54. The specific activation of the PAC’s
BLUF domain with light of a wavelength shorter than 500 nm
allows activation of red-shifted channelrhodopsins at maximum
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intensity. Still, the blue light used for PAC-K activation can
potentially trigger an AP by activation of the red-shifted chan-
nelrhodopsin (Fig. 4e). However, given the extremely high light
sensitivity of PAC-K (Fig. 1c) to blue and UV light, combined
with the ability to integrate light over time (Fig. 3e), one can
minimize activation of any co-expressed channelrhodopsin. Thus,
bidirectional optical control of membrane voltage is feasible by
expressing the actuator and inhibitor either in genetically distinct,
but anatomically overlapping cell populations, or by co-
expressing activator and inhibitor within the same cell type, as
shown here for the combination of split-bPAC-K and bReaChES.
Our new tool is useful in a variety of model systems and across
disciplines exploring excitable cell systems, from the neu-
rosciences to cardiovascular research.
An important aspect of a cAMP-based two-component opto-
genetic silencer is that one has to consider other cAMP-induced
effects on intracellular signaling cascades, cellular metabolism,
and gene expression. However, it should be noted that the PAC-K
system was developed for silencing individual cells or cell
populations in intact tissue, whether in neuronal networks or in
the heart. These experiments allow one to study the functional
circuitry constituted by the remaining non-affected cells, rather
than the particular physiology of silenced cells. However, to
exclude cAMP-mediated side effects in experiments involving
multiple light applications over several days, it seems advisable to
use PAC-only expression as an appropriate control for cAMP
effects. bPAC-K represents a highly light-sensitive system due to
the light-integration of bPAC and the intrinsic amplification by
cAMP. Therefore, exposure of the PAC-K system to background
light <500 nm should be minimized whenever possible. In cell
types with low phosphodiesterase activity, baseline activity of the
PAC might be of concern, although we found little dark activity
across various experimental models, confirming previous
reports31,55. If required, the bPAC(S27A) variant39 with further
reduced dark activity could be used, as the mutant enzyme is
equally potent as wildtype bPAC in activating SthK (Supple-
mentary Fig. 1). To conclude, the PAC-K silencer represents a
novel genetically targetable light-controlled K+ channel that is
well expressed in a variety of model systems and cell types. It can
thus be exploited for a wide range of scientific research questions
for which efficient silencing of target cells is required.
Methods
Animal experiments. All animal experiments were carried out according to the
guidelines stated in Directive 2010/63/EU of the European Parliament on the
protection of animals used for scientific purposes and were approved by the local
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after the light pulse (2). Scale bars: 10 s, 100 pA (overview trace); 50ms, 100 pA (test pulses). c split-bPAC-K-mCherry expression in hippocampal slice of
a parvalbumin-Cre transgenic mouse. Note the dense mCherry labeling in stratum pyramidale showing axons from parvalbumin-positive interneurons.
Scale bar: 25 µm. d Quantification of the light-induced reduction in input resistance (IR), hyperpolarizing current amplitude, and time to peak after light
pulse (pyramidal neurons: n= 16 from two mice; interneurons: n= 10 from three mice). e Suppression of current ramp-elicited APs by illumination. In
pyramidal cells and parvalbumin-Cre+ interneurons, first spikes reappeared after 58 ± 5 and 43 ± 7 s, respectively (pyramidal neurons: n= 15 from two
mice; interneurons: n= 8 from three mice). Scale bars: 10 s, 20mV. f Repetitive illumination (every 20 s for 5 ms) caused long-lasting but reversible
inhibition of constant current-elicited spiking (n= 4, one mouse). Scale bars: 20 s, 10 mV. g Two-photon activation of fused-bPAC-K in CA1 neurons. The
two-photon laser was either positioned over the soma of a fused-bPAC-K-positive neuron, or shifted ~80 µm to an adjacent area. Scale bar: 10 µm. h
Inhibition of firing by the two-photon beam pointing at the soma (closed circles) or shifted from the soma (open circles, n= 10, three mice). Data in panel
a–f was obtained with split-bPAC-K, while data in panel g and h was obtained with fused-bPAC-K. Scale bars: 1 s, 25 mV. Error bars in all graphs represent
SEM
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authorities in Baden-Württemberg (Regierungspräsidium Freiburg, X-16/10R),
Bayern (Government of Upper Bavaria/Regierung Oberbayern,
AZ.55.2-1-54-2532-101-12), Berlin (Berlin state government/Landesamt für
Gesundheit und Soziales, G0092/15 and G150/17), and Nordrhein-Westfalen
(Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein Westfalen
(LANUV), AZ 84-02.04.2014.A254), Germany. No randomization or blinding was
performed for the animals used in the study. We did not perform a power analysis
to determine sample size prior to the experiments, since the aim of our study was to
establish a new technology without prior knowledge on effect size and variability.
Unless otherwise stated, all chemicals were purchased from Sigma Aldrich, Carl
Roth, Tocris, and Thermo Fisher Scientific. Data are presented as mean ± SEM.
Molecular biology. SthK, bPAC, NgPAC1, TpPAC, OaPAC, and IcPAC (Acc. no.:
WP051071283.1) coding DNA sequences were obtained by gene synthesis. Two
construct configurations were used (Fig. 1a). In the cleavable configuration (split-
PAC-K), the SthK channel is separated from the PAC by a 2A ribosome skip
peptide from porcine teschovirus-1 (P2A)56. In the fusion protein variant (fused-
PAC-K), SthK is linked to the C-terminus of the PAC (TpPAC or bPAC) by a
peptide sequence (PRTYETSQVAPAGAP). In all cases, mCherry served as fluor-
escent marker. The wavelength used to excite mCherry did not overlap with the
excitation spectrum of the PACs. Expression cassettes for PAC-SthK-T2A-
mCherry and SthK-P2A-PAC-Cherry were subcloned into a pCS2-CMV-based
plasmid for characterization in ND7/23 cells. Different PAC variants (Fig. 1b, c,
Supplementary Fig. 1a, b) were compared using the cleavable PAC-K configuration.
For expression in cardiomyocytes, SthK-P2A-bPAC(wt)-mCherry or bPAC
(S27A)-SthK-T2A-mCherry were cloned into pAdeno-CMV (Clontech) using the
Adeno-X Adenoviral System (Clontech). Adenovirus was provided by the Viral
Core Facility of the Charité—Universitätsmedizin Berlin, Germany.
Similarly, we designed two viral expression constructs for neuronal expression:
For the split-PAC-K configuration, we inserted SthK-P2A-bPAC(wt)-mCherry or
SthK-P2A-TpPAC-mCherry into the CW3SL AAV expression vector57 containing
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a small CaMKIIα promoter and a chimeric WPRE/poly-A element. For the fused-
PAC-K configuration we created an AAV encoding bPAC(S27A)-SthK-T2A-
mCherry, with a synapsin promoter driving expression of the construct. For
experiments involving the red-shifted ChR bReaChES, EGFP-P2A-bReaChES was
obtained by gene synthesis and inserted into CW3SL. SthK-P2A-bPAC-mCherry
and EGFP-P2A-bReaChES were thus expressed by separate AAVs. For Cre-
dependent expression of the PAC-K silencer, Sthk-P2A-bPAC-Cherry was inserted
into a Flex-and-Excision (FLEX) cassette58 downstream of a synapsin promoter.
Adeno-associated viral particles of serotype 9 or 1 were produced according to
published protocols59. Briefly, HEK 293 cells (ATCC CRL-1573) were transfected
with a mix of pAD deltaF6, pAAV2/9, or pAAV 2/1, and the AAV expression
vector. 48 h post transfection, cells were resuspended, collected by centrifugation,
lysed in 50 mM Tris–Cl, 150 mM NaCl, and the viral particles were purified using
an iodixanol gradient purification process. See Supplementary Table 2 for the use
of the different constructs in each individual experiment.
Combined imaging of cAMP levels and electrophysiology. Viral transduction of
the cAMP sensor was performed according to the manufacturer’s protocol (Red
Fluorescent cAMP assay, Montana Molecular). In brief, 9 × 104 HEK 293 cells were
mixed with the BacMam stock, complete medium, and sodium butyrate and plated
on coverslips in a multi-well plate. Cells were incubated for 30 min at room
temperature in the dark and then for 24 h at 37 °C and 5% CO2. After 24 h, cells
were transfected with the bPAC-SthK fusion construct using Lipofectamine 2000
(Thermo Fisher), according to the manufacturer’s protocol. 24–48 h after trans-
fection, cells were transferred to a recording chamber placed on an inverted
microscope (Olympus IX71). bPAC was stimulated using a Xenon discharge lamp
(JML-C2,Rapp OptoElectronik) at 100 V passing through a 470 nm excitation filter
(Semrock, USA). Fluorescence of cADDis was recorded using a single-cell
fluorometry system (Photon Technology International) with excitation light of 560
± 3 nm; emission passed through a 641/75 nm filter (Semrock) onto a photon-
counting photomultiplier tube. Currents were recorded in voltage-clamp mode
(−40 mV) in the whole-cell configuration with an Axopatch 200B amplifier
(Molecular Devices). The extracellular solution contained (in mM): NaCl 140, KCl
5.4, MgCl2 1, CaCl2 1.8, HEPES 5, glucose 10, adjusted to pH 7.4 with NaOH. The
intracellular solution contained (in mM): NaCl 10, KAsp 130, EGTA 1, MgCl2 1,
Na2ATP 2, HEPES 10, adjusted to pH 7.2 with KOH.
Electrophysiology in ND7/23 cells. ND7/23 cells (ECACC 92090903, purchased
from Sigma-Aldrich) were cultured in DMEM medium supplemented with 5% fetal
calf serum (FCS). For electrophysiological recordings 5 × 104 cells were plated on
15-mm glass coverslips coated with Poly-D-Lysine. Cells were kept at 37 °C and 5%
CO2. After 24 h cells were transfected using Fugene® HD reagent at 3:1 reagent:
DNA ratio according to the manufacturer’s protocol (Promega).
Two days after transfection, whole-cell recordings in voltage-clamp mode were
performed using a Multiclamp 700B amplifier (Molecular Devices). Signals were
filtered at 4 kHz, digitized at 10 kHz, and recorded with Clampex 10.4. Electrodes
with resistance between 2 and 3MΩ were pulled in a horizontal micropipette puller
P1000 (Sutter instrument) from borosilicate glass capillaries with filament
(Harvard Apparatus; PG150T-15). An agar bridge containing 140 mM NaCl was
used with the reference electrode. While recording, cells were maintained at room
temperature and clamped at −40 mV. Extracellular buffer contained (in mM): 10
HEPES, 140 NaCl, 2.4 KCl, 2 CaCl2, 4 MgCl2, 10 glucose, pH 7.4, 300 mOsm.
Intracellular buffer contained (in mM): 17.8 HEPES, 135 K+ gluconate, 4.6 MgCl2,
4 MgATP, 0.3 NaGTP, 1 EGTA, 12 Na2-phosphocreatine, 50 phosphocreatine
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kinase, pH 7.3, 300 mOsm. pH was adjusted with N-Methyl-D-glucamine NMG.
Light stimulation was provided by a Mightex light source coupled to an Olympus
IX-73 microscope. PACs were illuminated for 10 or 100 ms with a 470 nm LED
through a LUCPLFLN ×60/0.7 Olympus objective. Illumination field was 0.102
mm2. Light intensities ranging from 0.11 to 100 mWmm−2 were applied for light
titration curves and the data was fitted using a logistic function. Maximum current
was defined as the maximum current amplitude obtained when saturation of the
channel was achieved. The slope of each current was calculated from a linear fit
made from the signal onset (3× signal noise) to the half peak amplitude. Latency
was defined as the time between the beginning of the light stimulus and the signal
onset. Data was analyzed using Clampfit 10, Origin 9, and GraphPad Prism 5.
Two-group comparison statistics were performed using the Wilcoxon Rank Sum
Test.
Action spectra for bPAC, TpPAC, and bReaChES were measured on an
Axiovert 100 Carl Zeiss microscope. Light was delivered through a W Plan-
Apochromat ×40/1.0 DIC objective (Carl Zeiss) with a Polychrome V light source
(TILL Photonics). Illumination field was 0.066 mm2. The half bandwidth was set to
±7 nm for all data points, and light exposure time was controlled with a shutter
system (VS25 and VCM-D1, Vincent Associates). In order to obtain the same
photon irradiance for all wavelengths (Photon count: 2.34 × 1013 photons s−1), a
motorized neutral density filter (NDF) wheel (Newport) was placed between the
Polychrome V and the microscope. When necessary, a filter between the
polychrome and the NDF was employed using a motorized 12-position filter wheel
(Thorlabs).
Cell isolation and culturing of primary cardiomyocytes. Rabbits (9/10 weeks of
both sex, total N= 16) were anesthetized via intramuscular injection of ketamine
(12.5 mg/kg body weight)/xylazine 2% (0.2 ml/kg body weight). During anesthesia
1000 units heparin and 0.5 mg ketamine were given intravenously. Thiopental
(12.5 mg/ml) was injected intravenously until apnea. The heart was excised, washed
in base solution (in mM: 137 NaCl, 4 KCl, 10 HEPES, 10 creatine, 20 taurine, 10
glucose, 1 MgCl2, 5 adenosine, 2 L-carnitine, 1 CaCl2, 5 units/ml heparin-sodium,
pH 7.4, 37 °C) including 1000 units heparin. The aorta was cannulated, the heart
transferred to a Langendorff perfusion setup and it was perfused with base solution
to wash out the blood. The heart was then perfused with calcium-free solution (in
mM: 137 NaCl, 14 KCl, 10 HEPES, 10 creatine, 20 taurine, 10 glucose, 1 MgCl2, 5
adenosine, 2 L-carnitine, 0.096 EGTA, pH 7.4, 37 °C) and finally digested with
enzyme solution (calcium-free solution with 0.1 mM CaCl2, collagenase type 2 (0.6
g/l, 315 U/mg) and protease XIV (0.03 g/l)). Left ventricle and septum were
separated and the tissue was pulled apart in blocking solution (calcium-free
solution with 0.1 mM CaCl2, 0.5% bovine serum albumin).
After digestion cell suspensions were filtrated using a 1-mm mesh and
centrifuged for 2 min at 22×g. Fibroblasts remaining in the supernatant were
removed and cardiomyocytes were resuspended in plating medium (5 mM
creatine, 2 mM L-carnitine hydrochloride, 5 mM taurine, 1 mM sodium pyruvat,
0.25 U/l insulin, 10 µM cytosine-β-D-arabinofuranoside, 5% FCS, and 0.05 mg/ml
gentamycin). Cardiomyocytes were cultured on laminin-coated (100 µg/ml)
coverslips. Medium was exchanged at 3–4 h after seeding cells, and adenovirus
(type 5) coding for either of the two constructs was added immediately after
medium exchange (MOI75 for 48 h). Medium was renewed after 48 h and cells
were recorded using the patch-clamp technique.
Patch-clamp recordings and contraction tracking of cardiomyocytes. Whole-
cell patch-clamp measurements on single isolated cardiomyocytes were performed
at room temperature using an inverted DMI 4000B microscope (Leica Micro-
systems), an Axopatch 200B amplifier, and an Axon Digidata 1550A (Molecular
Devices). Activation light was delivered by a 460 nm LED using a 460–480
nm bandpass excitation filter and controlled via custom-built hardware (Essel
Research and Development). External bath solution contained (in mM): 140 NaCl,
5.4 KCl, 1 CaCl2, 2 MgCl2, 10 glucose, 10 HEPES, pH 7.4, 300 mOsm; internal
solution (in mM) 50 KCl, 80 K-aspartate, 2 MgCl2, 3 Mg-ATP, 10 EGTA, 10
HEPES, pH 7.4, 300 mOsm. In current-clamp mode APs were triggered by current
injections of 50% more than the threshold to elicit an AP, using a current ramp
from 0 pA to 50% above threshold within 10 ms. Light pulses (460 nm/10 ms) were
applied after 15 current injections and recordings were continued until APs
reappeared. The AP duration (APD90) was determined using the 90th percentile of
the signal above resting potential as described60. Depolarizations with peak
amplitudes below 0 mV were marked as inhibited. In voltage-clamp mode cardi-
omyocytes were clamped to −60 mV and light (460 nm/10 ms) was applied
after 5 s.
Cardiomyocyte contractions were followed by detecting changes in sarcomere
length. To this end, cardiomyocytes were imaged with a MyoCam-S camera
(IonOptix) on an inverted microscope (DM IRBE, Leica Microsystems). Sarcomere
length was calculated in real time by a Fast Fourier Transform of the power
spectrum of the striation pattern (IonWizard, IonOptix)61. Cells were field
stimulated at 14 V/0.25 Hz with a Myopacer (IonOptix). A blue light pulse (460
nm/100 ms) was applied after 88 s. Data was analyzed with pClamp 11, OriginPro,
GraphPad Prism 7 and Matlab.
Electrophysiology on neuronal cultures. Hippocampal neurons prepared from
P0 C57/BL6-N mice of either sex were grown on a glial cell feeder layer at a density
of 1.25 × 104 cells cm−2 in 24-well plates in Neurobasal-A supplemented with 2%
B27 and 0.2% penicillin/streptomycin (Invitrogen). AAV particles were added
1–4 days after plating at a final concentration of 4.5 × 109 viral particles/ml for
split-bPAC-K and 1 × 109 particles/ml for bReaChES. Cells were used for record-
ings after 15–21 days in vitro.
Whole-cell and cell-attached recordings were performed on an Olympus IX73
inverted microscope using a Multiclamp 700B amplifier (Molecular Devices) under
the control of Clampex 10 (Molecular Devices). Data was acquired at 10 kHz and
filtered at 3 kHz. Extracellular solution contained (in mM): 140 NaCl, 2.4 KCl, 10
HEPES, 10 glucose, 2 CaCl2, and 4 MgCl2 (pH adjusted to 7.3 with NaOH, 300
mOsm). Synaptic currents were blocked by 5 µM NBQX and 4 µM gabazine in
most recordings. The intracellular solution contained (in mM): 135 K+ gluconate,
17.8 HEPES, 1 EGTA, 4.6 MgCl2, 4 Na2-ATP, 12 disodium creatine phosphate, and
50 U/ml creatine phosphokinase, pH adjusted to 7.3 with KOH, 300 mOsm.
Membrane potential was set to −60 mV in whole-cell voltage-clamp recordings. In
current-clamp recordings, membrane potential was manually adjusted when cells
depolarized to more than −55 mV. Data was not corrected for a liquid junction
potential, unless for the analysis of the K+ reversal potential in Fig. 3d (liquid
junction potential of 22.6 mV). Recordings were terminated when holding currents
were >−200 pA. Pipettes contained extracellular solution for cell-attached
recordings. A TTL-controlled LED system (pE4000, CoolLED) was coupled into
the back port of the IX73 microscope by a single liquid light guide. Fluorescence
light was filtered using single band pass filters of a “Pinkel” quadband filter set
(AHF F66-415) and delivered through an Olympus UPLSAPO ×20, 0.75 NA
objective. Neutral density filters were used for experiments involving low-intensity
light stimulations. Illumination intensities above the objective were measured prior
to the experiments using a photodiode power sensor (Thorlabs S170C). bPAC was
activated by flashes from the 385 or 470-nm LED, while bReachES-triggered APs
were elicited by 5-ms flashes of a GYR LED passed through a 554/24-nm filter.
Experiments involving temperature shifts were performed on an Olympus BX51
upright microscope equipped with a TC01 temperature controller (Multichannel
Systems) and a CoolLED pE3 LED system. Excitation light of 470 nm was passed
through a 470/40-nm filter (AHF F56-319) and applied via a 60× Olympus
LumPlan FI 60 × 0.9 NA water immersion objective. Data was analyzed using
AxographX 1.6.
Recordings on hippocampal slices using bPAC-K. Wild type and parvalbumin-
Cre62 mice (P26–P84) of either sex were injected in the hippocampal formation
targeting area CA1 and the dentate gyrus with either AAV9.CamKIIα:SthK-P2A-
bPAC-mCherry, AAV2.hSyn.bPAC(S27A)-SthK-T2A-mCherry, or AAV9.hSyn:
FLEX(SthK-P2A-bPAC-mCherry), respectively. After 3–4 weeks, acute horizontal
slices of the hippocampal formation were prepared. In brief, animals were anes-
thetized and decapitated. Under continuous safe light illumination, brains were
quickly removed and placed in ice-cold artificial cerebrospinal fluid (ACSF) bub-
bled with carbogen (pH 7.4) containing (in mM): 87 NaCl, 26 NaHCO3, 10 glu-
cose, 2.5 KCl, 3.5 MgCl2, 1.25 NaH2PO4, 0.5 CaCl2, and 75 sucrose. Tissue blocks
containing the hippocampal formation were mounted on a vibratome (Leica VT
1200S, Leica Microsystems), cut at 300-μm thickness, and incubated at 35 °C for 30
min. The slices were then transferred to carbogen-bubbled ACSF containing (in
mM) 119 NaCl, 26 NaHCO3, 10 glucose, 2.5 KCl, 2 CaCl2, 2 MgSO4, and 1.25
NaH2PO4. The slices were stored at room temperature in a submerged chamber for
1–5 h before being transferred to the recording chamber.
Whole-cell voltage and current-clamp recordings were performed from the
hippocampal CA1 and CA3 area on an Olympus BX51 upright microscope.
Recording electrodes with 4–5MΩ resistance were pulled from borosilicate glass
capillaries (Harvard Apparatus, Kent, UK; 1.5 mm OD) using a micropipette
electrode puller (DMZ Universal Puller). The intracellular solution contained (in
mM): 130 K-gluconate, 7 KCl, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP, 10 Na-
phosphocreatine, and 0.2% (w/v) biocytin, pH 7.25 adjusted with KOH, 300 mOsm
or K+ gluconate 127, KCl 20, HEPES 10, EGTA 0.16, Mg-ATP 4, Na2-ATP 2, D-
glucose 10 (pH 7.25 (KOH), 295 mOsm). Membrane potential was set to −60 mV
in whole-cell voltage-clamp recordings and at resting membrane potential in
current-clamp recordings. Infected cells were identified by mCherry fluorescence.
Excitation light of 470 nm from a CoolLED pE2 LED system was passed through a
filter (AHF F56-319) and applied via a ×60 Olympus LumPlan FI 60 × 0.9 NA
water immersion objective. Data was acquired using a Multiclamp 700B or BVC-
700A amplifier (Molecular Devices or Dagan, respectively) under the control of
Clampex 10.0 (Molecular Devices) at 10 kHz and filtered at 3 kHz. Recordings were
analyzed using Clampfit (Molecular Devices) or AxographX 1.6.
A subset of electrophysiologically characterized neurons filled with 0.2%
biocytin were fixed overnight in 4% paraformaldehyde dissolved in phosphate-
buffered saline (PBS, pH 7.2). Recorded cells were visualized by 24 h incubation in
PBS supplemented with streptavidin-coupled Alexa 488 (Invitrogen). After
washing, the slices were mounted on slides and covered with Mowiol 4-88 (Carl
Roth). Images were aquired using a Leica SP5 confocal laser scanning system.
Two-photon photostimulation was performed using a microscope equipped
with a galvometer-based scanning system (Prairie Technologies, Ultima). A ROI
was defined covering the neuronal soma and stimulation was carried out by
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07038-8
10 NATURE COMMUNICATIONS |          (2018) 9:4611 | DOI: 10.1038/s41467-018-07038-8 | www.nature.com/naturecommunications
scanning the ROI with an ultrafast, Ti:sapphire pulsed laser (Chameleon Ultra,
Coherent) tuned to 930 nm (50 ms scan duration, laser power <20 mW).
In vivo Ca2+ imaging. We used 6–12-week-old wild type C57Bl/6 mice of both sex
for all two-photon experiments. To express fused-bPAC-K and GCaMP6s in CA1
pyramidal cells, we co-injected both AAV2.hSyn.bPAC-SthK-T2A-mCherry.
WPRE.SV40 and AAV1.Syn.GCaMP6s.WPRE.SV4042. Coordinates for stereotactic
virus injection were (from Bregma in mm): −2.0 AP, −1.4 ML, and −1.4 DV.
Cranial window preparations followed a former description63 and were
performed under isoflurane anesthesia (2% in oxygen) as follows. Eyes were
covered with eye-ointment (Bepanthen, Bayer) to prevent drying and body
temperature was maintained at 37 °C using a regulated heating plate (TCAT-2LV,
Physitemp) and a rectal thermal probe. The cranial bone was exposed, cleaned
from connective tissue, and covered with optical adhesive dental cement (OptiBond
FL, Kerr). A flat custom-made head post ring was fixed with UV curable dental
acrylic (Tetric EvoFlow, Ivoclar Vivadent) to allow a close approach of the objective
to the skull. A circular craniotomy (⌀ 3 mm) was opened above the right
hemisphere hippocampus using a dental drill. Cortical tissue was aspirated using a
27-gauge needle until the fiber tracks of the corpus callosum became visible. A
custom-made cone-shaped silicon inset (upper diameter 3 mm, lower diameter 2
mm, RTV 615, Movimentive) covered by a cover glass (⌀ 5 mm, thickness 0.17
mm) was inserted and fixed with dental acrylic. This special window design allowed
easy implantation and maintenance, and the geometry was optimal for conserving
the numerical aperture of the objective. The imaging session was conducted under
anesthesia directly after surgery.
We used a commercially available two-photon microscope (A1 MP, Nikon)
equipped with a 25× long working distance, water immersion objective (NA= 1,
WD= 4 mm, XLPLN25XSVMP2, Olympus) controlled by the NIS-Elements
software (Nikon). GCaMP6s was excited at 1000 nm using a Ti:sapphire laser
system (~60 fs laser pulse width; Chameleon Vision-S, Coherent). At 1000 nm,
flavoproteins are not excited by two-photon lasers41, allowing separate excitation of
the GCaMP with no cross-talk to the silencer. Emitted photons were collected
using gated GaAsP photomultipliers (H11706-40, Hamamatsu) that electrically
protected the optical sensor during light stimulation and quickly (~µs) recovered
sensitivity afterwards. Stimulation light was delivered using a 488-nm diode laser
(Sapphire 488 LP, Coherent) through the microscope galvanometric scanning unit
in parallel to the imaging. Activity was acquired with a resonant scanning system at
a frame rate of 15 Hz and duration of 10 min per movie. A 20-ms stimulation light
pulse was delivered in the middle of each movie and five movies were recorded for
every field of view. For excitation of mCherry we used a fiber laser system at 1070
nm (55 fs laser pulse width, Fidelity-2, Coherent) and recorded a reference image
for every field of view.
To remove movement artifacts caused by breathing, recorded movies were
registered using the steady scan Matlab toolkit64. Individual cell fluorescence traces
were identified and Ca2+ events were deconvolved using a constrained non-
negative matrix factorization-based algorithm65. For later analysis, only
components found in all five movies and showing a signal above threshold in the
reference image were taken into account. We binarized Ca2+ events by taking the
onset of every event independent of event amplitude. Event probability was
calculated by summing up the binarized events of all cells in all five movies within
time bins of one second. We calculated the activity onset after stimulus for each
individual cell by averaging the time to the first identified event after stimulus from
all five movies.
In vivo silicon probe recordings. We injected 3× 200–300 nl of AAV9.CamKIIα:
SthK-P2A-bPAC-mCherry into the left hemisphere of C57Bl6N mice (P26–P41,
both sex) at coordinates (in mm relative to Bregma) AP −2.0, ML −1.6, DV −2.1,
−1.7, −1.3. Four to six weeks after the stereotaxic injection, mice were anesthetized
first with isoflurane (~2% in oxygen) and then by two i.p. injections (~10–15 min
intervals) of 10% w/v urethane (total dose 1.8–2 g/kg) while lowering the isoflurane
level under constant checking of breathing pattern and reflexes. Once a sufficient
level of anesthesia was reached, mice were inserted into a stereotaxic frame and a
craniotomy was performed at the same site as the original stereotaxic surgery. A
32-channel silicon probe (A1×32-poly2/3-10 mm-50-177-OA32LP, Neuronexus)
with an integrated light guide (105 µm core, NA 0.22), attached to a reference wire
with an Ag/AgCl pellet placed on the skull, was then inserted into the brain to a
depth of 1550–2450 µm. Recordings were performed at depths of 1550–1800 µm
using an RHD 2132 amplifier chip with an integrated 16-bit analog-to-digital
converter and an RHD2000 USB interface board (Intan Technologies, Los Angeles,
CA, USA). The light guide was coupled to an MBL-III-473 laser (100 mW, CNI,
Changchun, China) producing pulses of 10 or 100-ms duration. Since no differ-
ences in response were observed, we pooled trials with both durations. Inter-pulse
intervals were at least 3 min. At the end of each experiment, mice were killed with
an overdose of urethane. We then performed cardiac perfusion with 0.1 M PBS
followed by 4% paraformaldehyde (PFA) before removal of the brain and overnight
fixation in PFA. Coronal sections (100 µm) were cut on a vibratome and imaged
with a fluorescence microscope (Leica) to allow identification of mCherry-labeled
cells, as well as to visualize the track left by the silicon probe. We confirmed that
recordings from all mice were acquired in the hippocampal area CA1, and that the
recording sites overlapped with the mCherry-labeled injection sites. As the aim of
this experiment was to obtain a qualitative impression of the construct’s effec-
tiveness in inhibiting neuronal activity in mouse brain in vivo, and because we
observed a very clear effect with the first three mice, no further animals were used.
A more formal evaluation and quantification is beyond the scope of this study.
Zebrafish experiments. Zebrafish were raised in Danieau’s solution (17 mM
NaCl, 2 mM KCl, 0.12 mMMgSO4, 1.8 mM Ca(NO3)2, 1.5 mM HEPES) at 28 °C in
the dark to avoid unwanted activation of bPAC-SthK. The following transgenic
lines were used: Et(−0.6hsp70l:Gal4-VP16)s1020t66 and UAS:bPAC-SthK-
tagRFPTmpn157 (see below), referred to as Gal4s1020t and UAS:bPAC-K-tRFPtmpn157
in the text and figures, respectively.
Generation of bPAC-SthK-tRFPtmpn157 transgenic zebrafish. Sequence encoding
bPAC(wt)-SthK was fused to TagRFPT and placed downstream of the MCS of the
upstream activating sequence (UAS) containing the Tol2 transposon system
(pTol2-14xUAS, Baier laboratory). The assembly was performed with the In-
Fusion® PCR cloning system (In-Fusion HD Cloning Kit, TaKaRa Clontech, Cat.
#639649). The gene encoding the fluorescent protein TagRFPT was amplified from
the following plasmid: UAS:lyn-tagRFPT67. The construct (25 ng/μl) was injected
into eggs with the TL genetic background at the one-cell stage together with
zebrafish codon–optimized Tol2 transposase mRNA (50–100 ng/µl) synthesized
from pCS-zT2TP68.
Confocal imaging of zebrafish embryos. F1 embryos (22–25 hpf; sex not
determined) were dechorionated and mounted in 2.5% low melting agarose in
Danieaus solution. Fish were imaged with a Zeiss LSM700 confocal microscope
with a ×20 water immersion objective.
Inhibition of spontaneous movement in the coiling assay. Zebrafish embryos
were placed in a 48-well plate well, inside a dark, temperature-controlled behavior
box. After several minutes of adaptation, spontaneous coiling movements were
recorded using an IR-sensitive camera (Mikrotron EoSens). Three recordings were
carried out for each condition, with 2-min intervals in between. Activation light for
bPAC was provided by a blue (455 nm) or red (625 nm) LED (Thorlabs) placed
~15 cm above the samples and controlled by a custom-written Python code using a
LabJack U3. Light intensity was measured at the location of the sample with an
Energy Meter Console (PM100D, Thorlabs).
Image analysis was performed with custom-made python scripts (available upon
request) following a published protocol as follows69. Single circular regions of interests
(ROIs) were manually drawn around the chorion of each embryo. To identify
movements of the embryo, every frame was subtracted from the previous frame. For
each ROI, single coiling movements were identified from a series of frames in which
the pixel values changed between frames above a pre-defined noise threshold.
Embryos that did not show any coiling movement during the whole recording were
removed from the analysis. The average coiling frequency was then calculated across
embryos of a single trial and across the three trials, for each condition.
Data collection and analysis. Statistical analysis was performed in MATLAB,
OriginPro, or GraphPad Prism v5-v7. Data are presented as mean ± standard error
of the mean (SEM), if not stated otherwise, and were tested for normality and equal
variance. Animal numbers were chosen due to electrophysiological standards to
distinguish an in the forehand unknown effect size from chance level. Sample sizes
were not predetermined by statistical methods but are similar to those reported in
comparable previous publications3,7. For light titration experiments, different light
intensities were applied in a randomized fashion to the recorded cells. Data col-
lection and analysis were not performed blind to the conditions of the experiments.
Code availability. Custom python scripts for image analysis are available upon
request.
Data availability
The data that support the findings in this study are available from the corresponding
author upon reasonable request. DNA constructs are available via Addgene at
https://www.addgene.org/118274/, https://www.addgene.org/118275/, https://www.
addgene.org/118276/, https://www.addgene.org/118277/, https://www.addgene.org/
118278/. Sequences have been uploaded to GenBank under accession codes
MK027462, MK027463.
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